100,000 Genomes Pilot on rare-disease diagnosis in health care - Preliminary Report

Smedley, Damian, Smith, Katharine A., Martin, Antonio, Thomas, Ellen A., McDonagh, Ellen M., Cipriani, Valentina, Ellingford, Jamie M., Arno, Gavin, Tucci, Arianna, Vandrovcova, Jana, Chan, Georgia, Williams, Hywel J. ORCID: https://orcid.org/0000-0001-7758-0312, Ratnaike, Thiloke, Wei, Wei, Stirrups, Kathleen, Ibanez, Kristina, Moutsianas, Loukas, Wielscher, Matthias, Need, Anna, Barnes, Michael R. and The 100,000 Genomes Project Pilot Investigators 2021. 100,000 Genomes Pilot on rare-disease diagnosis in health care - Preliminary Report. New England Journal of Medicine 385 (20) , pp. 1868-1880. 10.1056/NEJMoa2035790

Full text not available from this repository.

Abstract

Background The U.K. 100,000 Genomes Project is in the process of investigating the role of genome sequencing in patients with undiagnosed rare diseases after usual care and the alignment of this research with health care implementation in the U.K. National Health Service. Other parts of this project focus on patients with cancer and infection. Methods We conducted a pilot study involving 4660 participants from 2183 families, among whom 161 disorders covering a broad spectrum of rare diseases were present. We collected data on clinical features with the use of Human Phenotype Ontology terms, undertook genome sequencing, applied automated variant prioritization on the basis of applied virtual gene panels and phenotypes, and identified novel pathogenic variants through research analysis. Results Diagnostic yields varied among family structures and were highest in family trios (both parents and a proband) and families with larger pedigrees. Diagnostic yields were much higher for disorders likely to have a monogenic cause (35%) than for disorders likely to have a complex cause (11%). Diagnostic yields for intellectual disability, hearing disorders, and vision disorders ranged from 40 to 55%. We made genetic diagnoses in 25% of the probands. A total of 14% of the diagnoses were made by means of the combination of research and automated approaches, which was critical for cases in which we found etiologic noncoding, structural, and mitochondrial genome variants and coding variants poorly covered by exome sequencing. Cohortwide burden testing across 57,000 genomes enabled the discovery of three new disease genes and 19 new associations. Of the genetic diagnoses that we made, 25% had immediate ramifications for clinical decision making for the patients or their relatives. Conclusions Our pilot study of genome sequencing in a national health care system showed an increase in diagnostic yield across a range of rare diseases. (Funded by the National Institute for Health Research and others.)

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Schools > Medicine
Additional Information:	For a full list of authors in the The 100,000 Genomes Project Pilot Investigators, please follow links to the publishers page.
Publisher:	Massachusetts Medical Society
ISSN:	0028-4793
Last Modified:	12 Feb 2026 15:44
URI:	https://orca.cardiff.ac.uk/id/eprint/184753

Actions (repository staff only)

Edit Item